1. From the Deutsches Rheuma-Forschungszentrum Berlin, 10115 Berlin, Germany; the National Institutes of Health, National Cancer Institute, Laboratory of Tumor Immunology and Biology, Bethesda, Maryland 20892; and AMAXA GmbH, c/o Deutsches Rheuma-Forschungszentrum Berlin, 10115 Berlin, Germany